Stewards Inc. Announces Official Corporate Name and Ticker Change to 'SWRD' Transition to the Stewards Inc. name and ticker becomes effective Nov. 14, 2025. GlobeNewswire November 14, 2025 FORT LAUDERDALE, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) — via IBN – Stewards Inc. (OTC: SWRD), a diversified financial company operating across private credit, real assets and […]
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference GlobeNewswire November 14, 2025 WALTHAM, Mass. and BOULDER, Colo., Nov. 14, 2025 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its participation in the Jefferies Global Healthcare Conference in London on
CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates GlobeNewswire November 14, 2025 Initiated rolling Biologics License Application (BLA) submission to U.S. FDA for cretostimogene monotherapy in high-risk (HR) BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) Demonstrated continued best-in-disease durability and tolerability in BOND-003 Cohort C with robust 24-month complete response (CR) rate
SPAR Group, Inc. Reports Third Quarter 2025 Results Executing Strategy to Create a Structurally Leaner, Profitable Business GlobeNewswire November 14, 2025 CHARLOTTE, N.C., Nov. 14, 2025 (GLOBE NEWSWIRE) — SPAR Group, Inc. (NASDAQ: SGRP) (“SPAR,” “SPAR Group” or the “Company”), an innovative services company offering comprehensive merchandising, marketing, and distribution solutions to retailers and brands
BellRing Brands Appoints David Finkelstein to Board of Directors GlobeNewswire November 14, 2025 ST. LOUIS, Nov. 14, 2025 (GLOBE NEWSWIRE) — BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global convenient nutrition category, today announced that David Finkelstein has been appointed to its Board of Directors (the “Board”) and the Audit Committee,
Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update GlobeNewswire November 14, 2025 NORCROSS, Ga., Nov. 14, 2025 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three and
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire November 14, 2025 SOUTH SAN FRANCISCO, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee
Gauzy Ltd. to Reschedule Third Quarter 2025 Earnings Release GlobeNewswire November 14, 2025 Discloses that Insolvency Proceedings Have Commenced Related to Certain French Subsidiaries Gauzy Adamantly Opposes the Proceedings and Plans to Appeal as Soon as Possible Gauzy Working with Its Lenders to Ensure Financial Viability of Its French Subsidiaries TEL AVIV, Israel, Nov. 14,
Actelis Networks Reports Third Quarter 2025 Financial Results and Operational Update GlobeNewswire November 14, 2025 Customer bookings nearly doubled compared to Q2, with a stronger backlog entering Q4 2025 Recent Hire of U.S. Federal Sales leadership Supports market Opportunities Reorganization and efficiency plan on track toward annualized 15-20% operating expense reduction Cybersecurity, HW and software
BLAQclouds, INC. Announces Strategic Alignment with Metavesco (MVCO) Following Two-Day Leadership Summit GlobeNewswire November 14, 2025 ROBESONIA, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) — BLAQclouds, Inc. (OTC: BCDS), a next-generation Web3 infrastructure and multi-chain fintech company, today announced the successful completion of a two-day strategic summit with Ryan Schadel, CEO of Metavesco, Inc. (OTC: MVCO)